Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Short-Term Outcomes of Surgical Interventions for Acute Mesenteric Arterial Ischemia
 
Dhaval Mangukiya1, Keyur Bhatt1, Karshan Nandaniya2, Divya Mulchandani2
1Department of GI-HPB and Cancer Surgery, 2Department of Critical Care, Surat Institute of Digestive Sciences (SIDS), Surat, India.


Corresponding Author
:
Dr Dhaval Mangukiya
Email: drdhavalmangukiya@gmail.com


Abstract

Background: Acute thromboembolic occlusion of the superior mesenteric artery (SMA) has been associated with poor prognosis. The present study reports a single-center experience of surgical interventions in patients with acute occlusion of SMA.
Methods: This retrospective, observational study included patients who underwent surgical treatment for acute mesenteric ischemia due to thromboembolic occlusion of SMA. Short-term follow-up data included in-hospital morbidities and in-hospital mortality. Major in-hospital morbidities included peritonitis, sepsis or septic shock, multi-organ failure, re-occlusion of arteries, acute renal failure, re-exploration, and prolonged ventilation. Minor in-hospital morbidities were defined as the occurrence of ileus, surgical site infection, or any other complications that required further treatment or prolonged hospital stay. Long-term follow-up data included short bowel syndrome, readmission to hospital for reoccurrence of mesenteric ischemia, and death at 1-year follow-up.
Result: A total of 47 patients (average age 54.23±10.09 years) were included in the analysis. All the patients underwent exploratory laparotomy, with an average time from hospital admission to operation of 8.34±8.210 hrs. Except for three patients, all the patients needed bowel resection during the first surgical intervention. Open surgical revascularization with thromboembolectomy was attempted in 33 (70.2%) patients. Relook laparotomy was performed in 17 (n=17/47; 36.2%) patients. Five patients (n=2 further bowel resection; n= 3 resections at relook only) needed bowel resection during relook procedure. In-hospital and one-year mortality was 8.5% (n=4) and 36.2% (n=17), respectively. 
Conclusion: The results of the study demonstrated that surgical intervention for acute arterial mesenteric ischemia due to thromboembolic occlusion of SMA is an effective treatment approach.